Position in BMRN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$7,278,040
+$92,851 QoQ
Shares Held
127,194
0.0% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#130
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KBC Group NV holds $308,329,109 across 107 Biotechnology names. BMRN ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
179,508 | $111,930,417 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
128,466 | $63,812,914 | |
| 3 | INCY |
Incyte Corp
|
270,882 | $30,707,183 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
98,265 | $23,678,916 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
91,584 | $7,963,228 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,787,043 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
127,194 | $7,278,040 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $6,372,835 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,278,040 | 127,194 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $7,185,189 | 127,194 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $10,030,535 | 168,779 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $8,309,064 | 153,417 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $6,949,141 | 126,417 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,857,456 | 125,300 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $8,590,779 | 130,698 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $11,523,833 | 163,947 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $19,121,553 | 232,255 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $20,087,413 | 229,991 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $23,343,281 | 242,100 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $22,121,945 | 250,022 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $24,897,095 | 287,230 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $27,194,526 | 279,664 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $33,292,732 | 321,700 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $19,254,657 | 227,140 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $18,881,100 | 227,840 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $14,213,693 | 184,354 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $17,007,816 | 192,505 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $25,317,420 | 327,564 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $19,503,098 | 233,738 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $13,941,259 | 184,628 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $12,637,970 | 144,121 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $15,279,830 | 200,839 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $23,531,667 | 190,787 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $8,222,187 | 97,304 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||